Smith & Nephew SNATS - 19 Year Stock Price History | SNN

Historical daily share price chart and data for Smith & Nephew SNATS since 1999 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Smith & Nephew SNATS as of November 12, 2018 is 36.42.
Smith & Nephew SNATS Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 36.1312 34.4828 39.4400 32.4000 36.4200 5.29%
2017 33.4499 29.0858 38.0397 28.9985 34.5914 18.57%
2016 31.1232 33.1236 33.7470 26.2926 29.1731 -13.91%
2015 33.0517 33.6230 35.7159 30.9154 33.8851 -1.39%
2014 30.5152 26.0153 36.1359 26.0153 34.3619 30.43%
2013 21.8304 20.0105 26.3862 18.9943 26.3458 32.44%
2012 18.0384 17.2067 19.9854 16.0383 19.8920 17.38%
2011 17.9354 18.2290 20.8594 14.7383 16.9463 -6.95%
2010 16.4458 17.6319 18.4208 14.2157 18.2117 4.05%
2009 13.4541 10.9359 17.5465 10.2549 17.5021 61.53%
2008 18.0569 19.1150 22.7437 10.1945 10.8353 -43.11%
2007 19.9087 17.2136 22.4783 17.1150 19.0454 10.73%
2006 14.5628 15.3935 17.3056 12.0911 17.2004 14.17%
2005 15.5125 16.3482 16.9962 13.0858 15.0652 -9.50%
2004 15.7267 13.3335 18.5782 13.0021 16.6474 24.62%
2003 10.4821 9.7396 13.4801 8.4391 13.3590 38.19%
2002 9.0756 9.3830 10.0164 7.5856 9.6672 2.18%
2001 7.7082 7.0575 9.4764 6.4208 9.4608 33.70%
2000 6.0216 6.1602 7.0759 4.6837 7.0759 14.63%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $16.143B $4.765B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $127.843B 25.90
Medtronic (MDT) Ireland $127.434B 19.54
Stryker (SYK) United States $64.080B 24.15
Boston Scientific (BSX) United States $53.415B 26.99
Baxter (BAX) United States $33.780B 21.81
Zimmer Biomet Holdings (ZBH) United States $23.992B 15.56
ResMed (RMD) United States $15.239B 29.06
Canopy Growth (CGC) Canada $9.087B 0.00
Perrigo (PRGO) Ireland $8.704B 13.21
Bio-Rad Laboratories (BIO) United States $8.282B 52.95
Aurora Cannabis (ACB) Canada $7.005B 66.27
Hill-Rom Holdings (HRC) United States $6.451B 20.45
Haemonetics (HAE) United States $5.768B 50.73
Insulet (PODD) United States $5.175B 0.00
ICU Medical (ICUI) United States $4.749B 26.49
Hutchison China MediTech (HCM) China $4.266B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.158B 0.00
Agios Pharmaceuticals (AGIO) United States $4.020B 0.00
Neogen (NEOG) United States $3.320B 50.28
National Vision Holdings (EYE) United States $3.309B 73.08
Aphria (APHA) $3.074B 0.00
NuVasive (NUVA) United States $2.979B 27.72
Quidel (QDEL) United States $2.599B 33.88
NxStage Medical (NXTM) United States $1.933B 0.00
Phibro Animal Health (PAHC) United States $1.498B 21.20
AtriCure (ATRC) United States $1.262B 0.00
Cardiovascular Systems (CSII) United States $1.079B 1554.50
VAREX IMAGING (VREX) United States $1.035B 16.91
PetIQ (PETQ) United States $0.874B 28.60
Surmodics (SRDX) United States $0.855B 130.61
Meridian Bioscience (VIVO) United States $0.836B 26.65
OraSure Technologies (OSUR) United States $0.797B 44.86
Cerus (CERS) United States $0.778B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.775B 24.86
MacroGenics (MGNX) United States $0.734B 0.00
Omeros (OMER) United States $0.638B 0.00
Lantheus Holdings (LNTH) United States $0.575B 17.81
Insys Therapeutics (INSY) United States $0.568B 0.00
Owens & Minor (OMI) United States $0.567B 6.41
LeMaitre Vascular (LMAT) United States $0.527B 25.89
NanoString Technologies (NSTG) United States $0.475B 0.00
TG Therapeutics (TGTX) United States $0.459B 0.00
Evolus (EOLS) United States $0.416B 0.00
Quanterix (QTRX) United States $0.372B 0.00
Utah Medical Products (UTMD) United States $0.327B 21.12
Cytosorbents (CTSO) United States $0.312B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.280B 0.00
BioLife Solutions (BLFS) United States $0.258B 348.50
Surface Oncology (SURF) United States $0.227B 0.00
Rockwell Medical (RMTI) United States $0.225B 0.00
Chimerix (CMRX) United States $0.168B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.162B 0.00
Fonar (FONR) United States $0.143B 7.20
Chembio Diagnostics (CEMI) United States $0.117B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.091B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.077B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.074B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 21.60
Neurotrope (NTRP) United States $0.055B 0.00
CAS Medical Systems (CASM) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Capricor Therapeutics (CAPR) United States $0.030B 0.00
Valeritas Holdings (VLRX) United States $0.027B 0.00
Senestech (SNES) United States $0.020B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00